Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-13-000015

← back to feed
Filed
Oct 31, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Oct 2, 2013 111.55M sh
Operating Cash Flow Q1 2014 · Sep 30, 2013 −$2.11M
Operating Cash Flow Q1 2014 · Sep 30, 2012 −$54.7K
Cash And Equivalents Q1 2014 · Sep 30, 2013 $7.15K
Cash And Equivalents Q1 2014 · Jun 30, 2013 $7.05K
Stockholders Equity Q1 2014 · Sep 30, 2013 −$2.13M
Stockholders Equity Q1 2014 · Jun 30, 2013 −$2.05M
Total Liabilities Q1 2014 · Sep 30, 2013 $2.15M
Total Liabilities Q1 2014 · Jun 30, 2013 $2.07M
Current Assets Q1 2014 · Sep 30, 2013 $12.7K
Current Assets Q1 2014 · Jun 30, 2013 $12.26K
Net Income Q1 2014 · Sep 30, 2013 −$2.1M
Net Income Q1 2014 · Sep 30, 2012 −$52.1K
Operating Income Q1 2014 · Sep 30, 2013 −$2.39M
Operating Income Q1 2014 · Sep 30, 2012 −$52.1K